Rho-Kinase-IN-1

CAS No. 1035094-83-7

Rho-Kinase-IN-1( —— )

Catalog No. M26415 CAS No. 1035094-83-7

Rho-Kinase-IN-1 is a inhibitor of Rho kinase (ROCK) with Ki values of 30.5 and 3.9 nM for ROCK1 and ROCK2, respectively.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 260 Get Quote
10MG 410 Get Quote
25MG 678 Get Quote
50MG 954 Get Quote
100MG 1287 Get Quote
500MG 2574 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Rho-Kinase-IN-1
  • Note
    Research use only, not for human use.
  • Brief Description
    Rho-Kinase-IN-1 is a inhibitor of Rho kinase (ROCK) with Ki values of 30.5 and 3.9 nM for ROCK1 and ROCK2, respectively.
  • Description
    Rho-Kinase-IN-1 is a inhibitor of Rho kinase (ROCK) with Ki values of 30.5 and 3.9 nM for ROCK1 and ROCK2, respectively.
  • In Vitro
    Rho-Kinase-IN-1 is a ROCK inhibitor which can be useful for treating diseases or conditions associated with excessive cell proliferation, remodeling, edema and inflammation.
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    ROCK
  • Recptor
    Caspase| PAFR| PARP
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1035094-83-7
  • Formula Weight
    352.5
  • Molecular Formula
    C20H24N4S
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 50 mg/mL (141.84 mM)
  • SMILES
    CSc1ccc(CN2CCCC(C2)Nc2ccc3[nH]ncc3c2)cc1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Wang JJ, Liu YX, et al. [Study on steroidal saponins from Dioscorea zingiberensis and their platelet aggregation activities]. Zhongguo Zhong Yao Za Zhi. 2014 Oct;39(19):3782-7. Chinese.
molnova catalog
related products
  • ROCK inhibitor-2

    ROCK inhibitor-2 is a selective dual inhibitor of ROCK1 and ROCK2 (IC50s of 17 nM and 2 nM, respectively).

  • ROCK2-IN-2

    ROCK2-IN-2 is a selective inhibitor of ROCK2 (IC50 of <1 μM).

  • BDP9066

    BDP9066 is a potent and selective MRCK inhibitor that inhibits MRCKβ and MRCKα/β and can be used for the prevention and treatment of skin cancer.